socalTECH

MARCH 4, 2013

Is Amgen the next source of the healthcare industry's venture capital deals? It might be, on news that Kevin Sharer , the former CEO of Thousand Oaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. READ MORE>>.

Venture Capital 191

Venture Capital Thousand Oaks Capital News 191

socalTECH

JULY 2, 2014

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. Financial terms of the investment were not disclosed. According to Teledyne, the investment also included a strategic partnership deal.

Thousand Oaks 147

Thousand Oaks Invest San Diego Design 147

socalTECH

DECEMBER 8, 2022

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Dantari has appointed Richard A. Markus, M.D., a co-founding managing director at Westlake.

Westlake Village 100

Westlake Village Thousand Oaks CalTech Funding 100

socalTECH

JANUARY 4, 2019

Atara Biotherapeutics , the biopharmaceuticals firm which has its manufacturing and research efforts based in Thousand Oaks, said on Thursday that its current President and CEO, Isaac Ciechanover, M.D., The reason for the CEO changeover was not announced by the company. plans to step down. Ciechanover is the founder of Atara.

Thousand Oaks 113

Thousand Oaks Research Invest Capital 113

socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners. As part of the funding, F-Prime's Thomas Beck and Ben Auspitz have joined the company's board.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. USVP has backed such companies as Sun Microsystems, New Focus, Check Point Software Technologies, and hundreds of others.

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113